Watch Online: CSL CEO at a White House Roundtable
Perreault made the case for a plasma-based hyperimmune to treat COVID-19.
Two-Minute Video: Rare Disease in Asia-Pacific
Get a quick introduction to The Economist Intelligence Unit survey about gaps in diagnosis and treatment.
CEO Paul Perreault at White House Roundtable
Perreault, representing the plasma industry, said an antibody treatment depends on additional donations from recovered patien…
Short, sweet and once a week
Subscribe to get three stories each week about rare disease patients and biotech innovations.
Internships During the New Normal
We’re celebrating National Intern Day from a distance this year and saying thanks to our adaptable interns working remotely.
Eating Healthy Amid the COVID-19 Pandemic
For people living with chronic illness, a nutritious diet can be one piece of the puzzle.
CSL’s New Chief Scientific Officer
Dr. Andrew Nash has a lot on his plate, but he really wants to see your latest data.